Mitochondrial Fidelity and Homeostasis
Mitochondrial Fidelity and Homeostasis
批准号:
10373977
负责人:
Oleh Khalimonchuk
金额:
$34.79万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-06-01 至 2024-03-31
关键词:
AddressAgeAmyotrophic Lateral SclerosisBioenergeticsBiogenesisBiologicalCardiovascular DiseasesCell SurvivalCell physiologyCellsClinicalDefectDegenerative DisorderDementiaDevelopmentDiseaseDissectionEtiologyEventFailureFoundationsGlaucomaGoalsHealthHomeostasisHumanInner mitochondrial membraneInvestigationKnowledgeMalignant NeoplasmsMediatingMitochondriaMitochondrial MatrixModelingMolecularNeuropathyOrganellesOrganismOutcomeParkinsonian DisordersPathologyPathway interactionsPhysiologicalProcessProphylactic treatmentProteinsProteomeQuality ControlRegulationResearchRoleSaccharomyces cerevisiaeSignal TransductionTherapeuticTimeVisionWorkYeastscost effective treatmenteffective therapyhearing impairmentinsightmitochondrial metabolismnovelpreservationprogramsprotein complexproteostasisrepairedspatiotemporal
中文摘要
项目总结/摘要
拟议研究计划的总体愿景是确定进化如何保守
线粒体质量控制模块的功能,以维持细胞的生存,以及如何这些功能可以
以实现临床效益。Khalimonchuk实验室的研究重点是提供一个更好的
了解介导线粒体生物发生、功能和完整性的多层过程。的
总体目标包括:1)彻底的分子特征的因素参与; 2)解剖他们的作用
相关生物学机制中的协同作用; 3)相关调节和
信号事件及其潜在的治疗相关性。为此,这个MIRA提案的重点是一组
介导线粒体保真度和保持正常线粒体功能的基本机制
在细胞/有机体的整个生命周期中。线粒体及其复合蛋白质稳态(Proteostasis)
网络涉及多种动态过程和途径,以适应稳态挑战和变化
随着时间这些机制的多方面生物学作用与正常细胞和细胞外基质高度相关。
生理学和广泛的人类疾病,目前还没有有效的治疗方法。进步
线粒体衰竭已经成为流行的退行性疾病的主要致病因素,
青光眼、听力损失、帕金森综合征、肌萎缩侧索硬化、各种神经病、痴呆,
心血管疾病和某些癌症。尽管有很多研究,但这些疾病的分子病因学
病理学仍不清楚。因此,更好地了解介导线粒体
保真度,功能和完整性,以及这些机制的失败如何驱动上述临床表现,
至关重要。由线粒体保真度和蛋白质稳态的总体主题统一,
研究计划旨在研究:1)蛋白水解控制/调节蛋白质稳定性的机制,
丰富,组装和修复内线粒体膜和2)如何微妙的蛋白质
线粒体基质中的稳态得以建立和维持。在每一种情况下,拟议的工作将
专注于一组专用的多功能因子,介导线粒体自我保护,
与人类健康有关。目标是解决有关关键职能作用的未解决问题,
分子因素使用两个称赞互补模型,酵母酿酒酵母和培养
人体细胞这项研究将揭示新的监管机制,动态整合,协调一致,
时空作用对于线粒体亚蛋白质组调节稳态损伤至关重要,
生理需求和挑战。该项目的成功成果将提供前所未有的
深入了解线粒体代谢,生物能量学和蛋白质稳态的协调和挑战
目前对年龄相关疾病机制的看法。它们还可以帮助开发新的
针对随年龄发生的退行性疾病和相关病理的治疗/预防策略。
英文摘要
PROJECT SUMMARY/ABSTRACT
The overall vision of the proposed research program is to determine how evolutionary conserved
mitochondrial quality control modules function to maintain cell survival, and how these functions can be
manipulated to achieve clinical benefits. Research in the Khalimonchuk lab is focused on providing a better
understanding of multilayered processes that mediate mitochondrial biogenesis, function and integrity. The
general goals include: 1) thorough molecular characterization of factors involved; 2) dissection of their roles
and concerted action in relevant biological mechanisms; and 3) investigation of associated regulatory and
signaling events and their potential therapeutic relevance. To that end, this MIRA proposal focuses on a group
of fundamental mechanisms that mediate mitochondrial fidelity and preserve normal mitochondrial functions
throughout a lifecycle of a cell/organism. The mitochondria and its complex protein homeostasis (proteostasis)
network involve multiple dynamic processes and pathways that adapt to homeostatic challenges and change
over time. The multifaceted biological roles of these mechanisms are highly relevant to both normal cellular
physiology and a wide range of human disorders for which no effective therapies presently exist. Progressive
mitochondrial failure has emerged as a central causative factor of prevalent degenerative diseases such as
glaucoma, hearing loss, Parkinsonism, amyotrophic lateral sclerosis, various neuropathies, dementia,
cardiovascular disorders, and certain cancers. In spite of much research, the molecular etiology of these
pathologies remains obscure. Thus, a greater understanding of the mechanisms that mediate mitochondrial
fidelity, function, and integrity, and how failure of these mechanisms drives the above clinical manifestations, is
of central importance. Unified by an overarching topic of mitochondrial fidelity and protein homeostasis, this
research program seeks to study: 1) the mechanisms that proteolytically control/regulate protein stability,
abundance, assembly, and repair within the inner mitochondrial membrane and 2) how a delicate protein
homeostasis in the mitochondrial matrix is established and maintained. In each case, the proposed work will
focus on a group of dedicated versatile factors that mediate mitochondrial self-preservation and are highly
relevant to human health. The goal is to address unresolved questions concerning the functional roles of key
molecular factors using two lauded complementary models, the yeast Saccharomyces cerevisiae and cultured
human cells. The research will uncover novel mechanisms of regulation, dynamic integration, and concerted
spatiotemporal action that are critical for mitochondrial sub-proteomes to adjust to homeostatic insults and
physiological demands and challenges. Successful outcomes from this project will provide unprecedented
insights into the coordination of mitochondrial metabolism, bioenergetics, and proteostasis and challenge
current views on mechanisms of age-associated maladies. They may also aid in the development of new
treatment/prophylaxis strategies against degenerative diseases and related pathologies that occur with age.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial Fidelity and Homeostasis
-
批准号:10597652
-
项目类别:
-
资助金额:$8.2万
-
财政年份:2019
-
负责人:Oleh Khalimonchuk
-
依托单位:
A Conserved Metalloprotease Required for Mitochondrial Maintenance and Protection
-
批准号:8818735
-
项目类别:
-
资助金额:$27.32万
-
财政年份:2014
-
负责人:Oleh Khalimonchuk
-
依托单位:
A Conserved Metalloprotease Required for Mitochondrial Maintenance and Protection
-
批准号:8920657
-
项目类别:
-
资助金额:$27.32万
-
财政年份:2014
-
负责人:Oleh Khalimonchuk
-
依托单位:
A Conserved Metalloprotease Required for Mitochondrial Maintenance and Protection
-
批准号:9277480
-
项目类别:
-
资助金额:$27.32万
-
财政年份:2014
-
负责人:Oleh Khalimonchuk
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: